Literature DB >> 6247516

Polypoid renal pelvic lesions in children.

R A Wicklund, E S Tank.   

Abstract

A case is presented of gross hematuria and a large polypoid renal pelvic mass in a 15-month-old boy. Operation revealed a Wilms tumor with limited parenchymal involvement and rupture into the collecting system. This rare presentation of nephroblastoma and its differentiation from other rare benign and malignant renal pelvic lesions occurring in the pediatric patient are discussed. The advantages and disadvantages of radical and conservative surgical approaches to these rare lesions are reviewed. Preoperative cystoscopy and retrograde pyelography are mandatory in all patients with renal tumors presenting with gross hematuria, regardless of age. Radical nephrectomy with total ureterectomy is recommended for Wilms tumor with extension into the collecting system.

Entities:  

Mesh:

Year:  1980        PMID: 6247516     DOI: 10.1016/s0022-5347(17)56205-9

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  4 in total

1.  Botryoid Wilms tumor: a non-existent "entity" causing diagnostic and staging difficulties.

Authors:  Gordan M Vujanić; Marco Schiavo Lena; Neil J Sebire
Journal:  Virchows Arch       Date:  2018-12-04       Impact factor: 4.064

2.  An infant presenting with a non-functional kidney on dimercaptosuccinic acid scan: answer.

Authors:  Neamatollah Ataei; Abbas Madani; Seyed Taher Esfahani; Alireza Sina; Abdolmohammad Kajbafzadeh; Maryam Monajemzadeh; Fatemeh Ataei
Journal:  Pediatr Nephrol       Date:  2009-06-30       Impact factor: 3.714

3.  Botryoid Wilms' tumor: a report of two cases.

Authors:  Toshihiro Yanai; Tadaharu Okazaki; Atsuyuki Yamataka; Hiroyuki Kobayashi; Geoffrey J Lane; Masahiro Saito; Hiroo Fujita; Yuuichiro Yamashiro; Takeshi Miyano
Journal:  Pediatr Surg Int       Date:  2005-01       Impact factor: 1.827

Review 4.  Botryoid Wilms' tumor: a case report and review of the literature.

Authors:  Guofeng Xu; Jimeng Hu; Yeming Wu; Yongtao Xiao; Maosheng Xu
Journal:  World J Surg Oncol       Date:  2013-05-20       Impact factor: 2.754

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.